Step by Step, Ferociously

The Latin phrase "gradatim ferociter" (step by step, ferociously) originates from a context far removed from enterprise software, but its operational philosophy reveals how lasting capability is built.

The phrase combines two ideas that most organisations see as contradictory. Patience in progress: a willingness to take incremental steps, to carefully plan work, and to resist the urge to skip stages for the sake of visible progress. Ferocity in execution: a refusal to accept mediocrity at any individual step, applying a standard of intensity to the immediate task regardless of how far it is from the final goal.

Most companies are comfortable with one of these. They either develop carefully but without urgency, or they deliver quickly and accumulate debt through shortcuts that eventually need rectification. Maintaining both at the same time requires a different discipline, and we have sought to embed it at Mitochondria.

Why sequencing matters

Agentic AI is a field where the temptation to skip steps is especially strong. The technology is capable. Models reason, plan, and act. The gap between a convincing demonstration and a real deployment can seem surprisingly small: the demo works, stakeholders are keen, and the pressure to speed up is genuine. The industry's incentive structure rewards rapid deployment and broad capability claims.

Our approach has been shaped by observation. The pattern across engagements, our own and those we have studied, remains consistent. Systems that skip the operational mapping phase tend to produce confident but incorrect results. They automate the documented workflow rather than the real one. They handle common cases smoothly but fail on the exceptions that define the operation.

Every Mitochondria deployment begins with a phase called Stimuli, during which we map the actual operation before making any configurations. This phase reveals what actually happens, where decisions are made, who makes them, what information they rely on, and what occurs when the usual decision-maker is unavailable. It also uncovers undocumented exceptions. This phase takes time and doesn’t produce artefacts that demo well. Instead, it yields a precise understanding of the operation the system must support. This understanding determines whether the deployment will last.

We have chosen not to shorten Stimuli for clients seeking earlier results. In every instance where we have maintained our approach, the deployment has been more stable, and the client relationship has consequently strengthened. We do not yet have an example where rushing would have been the better decision.

What ferocity looks like in practice

The standard applied at each step is where the second part of the philosophy operates. When we map an operation during Stimuli, we generate a configuration layer: the specific rules, exceptions, decision boundaries, escalation triggers, and accountability structures within which the product will function.

During Neuroplasticity, when we configure a product, we test it against the most critical cases. In manufacturing, this includes unusual configurations, margin-sensitive customers, and specifications that demand engineering judgment. A system that correctly handles 90% of cases may sound impressive, but the remaining 10% often involve cases where errors could have the highest consequences. These are the cases that must work flawlessly before anything goes live.

When a product goes live during Synthesis, we monitor it intensively, which isn't sustainable long-term but is necessary during initial testing under production conditions. Edge cases surface in integration. User behaviours not covered in the training data become apparent. System interactions cause delays in scenarios that seem simple on paper. In this phase, every anomaly is investigated, understood, and fixed before it worsens. The governance framework, audit trails, escalation procedures, and memory systems are internal components that the client may never see directly. They ensure the system performs reliably in key conditions. Building these to a standard that satisfies a regulator, an auditor, or a technically demanding client is the discipline that ferociter demands, whether or not anyone notices.

Applied to product development

The same philosophy guides our product development. Mitochondria manages products across manufacturing, eCommerce, financial services, agriculture, cross-border trade, research, field intelligence, and overall operational coordination. This wide scope did not come from a strategy of rapid expansion. Each product arose from a specific engagement in which we mapped an operational reality, developed a solution, and recognised that the core problem often existed across multiple organisations.

Cortex started with a single manufacturing client whose evaluation and costing processes relied entirely on knowledge held in senior engineers' heads. The product we developed for that engagement (a system that works alongside engineers, captures decision traces as work happens, and builds organisational memory over time) addressed a need shared by every custom manufacturer. The workflow architecture was carried over. The content of the decisions was always specific to each client. That distinction is what made it a product rather than a project.

The same pattern was observed across every product in our portfolio. A specific operational problem, studied carefully, solved thoroughly, and then examined for what it revealed about the broader problem class. We did not start with a product roadmap and fill it in. We began with operations and let the products develop from what we learned. The pace may seem slow compared to companies that announce product suites before building them, but each product in our portfolio exists because it solved a genuine problem for a real organisation. The architectural insights gained from each deployment inform the next.

The compounding effect

There is a reason this philosophy yields results that accelerate over time. Each deployment teaches us something about the problem class it belongs to. Each product deepens the platform architecture supporting all products. Each Stimuli phase refines our methodology for operational mapping.

A manufacturing deployment reveals insights into how organisations struggle to retain reasoning. That insight informs the design of memory in a financial services product. A field intelligence deployment uncovers how people communicate when they are away from a desk. That shapes the design of input handling for an agricultural support product. The products are distinct, yet operational learning travels between them.

This cumulative progress is possible because we do not skip steps. A hastily conducted engagement results in a deployed system, but a carefully executed engagement yields both a deployed system and transferable knowledge. The intensity applied to each step is what makes the knowledge valuable. The patience in sequencing is what ensures its robustness.

For organisations evaluating us

We are not the quickest choice. A client needing a system live within two weeks would be better served elsewhere. Our products, however, are autonomous in deployment and designed to operate with minimal ongoing supervision. The methodology is careful. The systems it produces are not tentative.

Our approach is deliberate, focused on creating something that remains functional and continues to improve a year from now. The organisations that find this appealing are those that have witnessed the consequences of deploying AI hastily and then neglecting it. They desire a system that performs reliably on an ordinary Wednesday, even when inputs are disorderly, and exceptions are genuine.

That is the standard we uphold. Step by step. Ferociously.

—

Mitochondria is an agentic AI product company based in Amsterdam, with operations in Pune. ISO 27001 certified. GDPR- and DPDP Act-compliant by architecture.